Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.

Brown, PJ; Ashe, SL; Leich, E; Burek, C; Barrans, S; Fenton, JA; Jack, AS; Pulford, K; Rosenwald, A; Banham, AH

Abstract:

The FOXP1 forkhead transcription factor is targeted by recurrent chromosome translocations in several subtypes of B-cell non-Hodgkin lymphomas, where high-level FOXP1 protein expression has been linked to a poor prognosis. Western blotting studies of diffuse large B-cell lymphoma (DLBCL) cell lines unexpectedly identified the atypical high-level expression of 2 smaller, 60 to 65 kDa, FOXP1 isoforms in all 5 of those with the activated B cell (ABC)-like DLBCL subtype and in a subgroup of prima...

Expand abstract

Publication status:

Published

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Brown, P. J., Ashe, S. L., Leich, E., Burek, C., Barrans, S., Fenton, J. A., Jack, A. S., Pulford, K., Rosenwald, A., & Banham, A. H. (2008). Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL. Blood, 111(5), 2816–2824.

MLA Style

Brown, P. J., et al. “Potentially Oncogenic B-Cell Activation-Induced Smaller Isoforms of FOXP1 Are Highly Expressed in the Activated B Cell-like Subtype of DLBCL.” Blood, vol. 111, no. 5, 2008, pp. 2816–24.

Chicago Style

Brown, PJ, SL Ashe, E Leich, C Burek, S Barrans, JA Fenton, AS Jack, K Pulford, A Rosenwald, and AH Banham. 2008. “Potentially Oncogenic B-Cell Activation-Induced Smaller Isoforms of FOXP1 Are Highly Expressed in the Activated B Cell-like Subtype of DLBCL.” Blood 111 (5): 2816–24.
Tweet
Print